Exhibit 99.1
Forma Therapeutics Highlights Etavopivat Development Expansion and Introduces New Oncology Program from Research Pipeline at Inaugural Research and Development (R&D) Day
Expanding etavopivat development in 2022 with Phase II trial exploring transfusion burden across sickle cell disease (SCD), thalassemia and myelodysplastic syndromes (MDS)
Phase 1 trial of FT-7051 in mCRPC proceeding with predicted efficacious dose range under evaluation and... (continue reading...)
Exhibit 99.1
Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer
RICHMOND, Calif., May 26, 2022 -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of Jerome Wong as Interim Chief Financial Officer following the departure of current CFO Jack Glenn. Mr. Glenn resigned effective June 17, 2022 to pursue a new position... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 25, 2022
WisdomTree Investments, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State or Other Jurisdiction
of Incorporation)
001-10932 13-3487784 ... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
Current Report
Pursuant to... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K Vera Therapeutics, Inc. For: May 24
-
Form 8-K WisdomTree Investments, For: May 25
-
Form 4 SQL Technologies Corp. For: May 24 Filed by: Shiff Dov
-
Form 8-K Broadcom Inc. For: May 26
-
Form 8-K Vroom, Inc. For: May 26
-
Form 6-K CANADIAN IMPERIAL BANK For: May 26
-
Form 10-Q BRADY CORP For: Apr 30
-
Form 6-K CollPlant Biotechnologie For: May 26
-
Form 10-Q DOLLAR GENERAL CORP For: Apr 29
-
Form 6-K SFL Corp Ltd. For: Mar 31
-
Form 6-K CANADIAN IMPERIAL BANK For: May 26
-
Form 6-K Can-Fite BioPharma Ltd. For: May 26
-
Form SD Vontier Corp
-
Form 6-K CANADIAN IMPERIAL BANK For: May 26
-
Form 8-K GENESCO INC For: May 26
-
Form 6-K CANADIAN IMPERIAL BANK For: Apr 30
-
Form 8-K ARCH RESOURCES, INC. For: May 25
-
Form 8-K AVADEL PHARMACEUTICALS For: May 24
-
Form 8-K DESTINATION XL GROUP, For: May 26
-
Form 8-K BRADY CORP For: May 24
-
Form D Jow Sports Medicine,
-
Form 497 ALLSPRING FUNDS TRUST
-
Form 425 COVA Acquisition Corp. Filed by: COVA Acquisition Corp.
-
Form 497 ALLSPRING FUNDS TRUST
-
Form 6-K CANADIAN IMPERIAL BANK For: May 26
-
Form 497 ALLSPRING FUNDS TRUST
-
Form 497 ALLSPRING FUNDS TRUST
-
Form 8-K COVA Acquisition Corp. For: May 26
-
Form 8-K Nurix Therapeutics, Inc. For: May 26
-
Form 6-K BRAZILIAN ELECTRIC POWER For: Jun 30
-
Form 8-K DOLLAR GENERAL CORP For: May 26
-
Form DEFA14A Daseke, Inc.
-
Form 8-K MARINUS PHARMACEUTICALS, For: May 25
-
Form 8-K JETBLUE AIRWAYS CORP For: May 26
-
Form 8-K Bloomin' Brands, Inc. For: May 25
-
Form DEF 14A Daseke, Inc. For: Jul 06
-
Form 8-K MOVADO GROUP INC For: May 26
-
Form 8-K BUILD-A-BEAR WORKSHOP For: May 26
-
Form 8-K Vontier Corp For: May 24
-
Form 8-K Akoustis Technologies, For: May 24
-
Form 6-K Manchester United plc For: May 26
-
Form 6-K Burford Capital Ltd For: May 26
-
Form 4 VOXX International Corp For: May 25 Filed by: Kahli Beat
-
Form 6-K Burford Capital Ltd For: May 26
-
Form 6-K Chindata Group Holdings For: May 26
-
Form 6-K Evogene Ltd. For: May 26
-
Form 8-K Thermon Group Holdings, For: May 26
-
Form 8-K Hamilton Lane INC For: May 26
-
Form 8-K Macy's, Inc. For: May 26
-
Form 497K NUVEEN INVESTMENT TRUST
